New drugs and new delivery techniques.
L G
LG
Feun
Y Y
YY
Lee
S
S
Wallace
C
C
Charnsangavej
N
N
Savaraj
C H
CH
Carrasco
C
C
Gianturco
W K
WK
Yung
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001388:Aziridines / Q000627:therapeutic use; D016227:Benzoquinones; D001761:Bleomycin / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy*; D016190:Carboplatin; D002330:Carmustine / Q000008:administration & dosage; D002945:Cisplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000295:instrumentation; D007372:Interferons / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D051381:Rats
D000970:Antineoplastic Agents; D001388:Aziridines; D016227:Benzoquinones; D009607:Nitrosourea Compounds; D009944:Organoplatinum Compounds; D001761:Bleomycin; D005047:Etoposide; D007372:Interferons; C018627:1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea; D016190:Carboplatin; C029108:diaziquone; D002945:Cisplatin; D002330:Carmustine